Hollsteen
← Microchip

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $60.0M · 10-Q 0000827054-15-000134 filed Aug 6, 2015D&A · Q2 FY2016: $71.0M · derived · 10-Q 0000827054-16-000472 filed Nov 8, 2016D&A · Q3 FY2016: $76.0M · derived · 10-Q 0000827054-17-000018 filed Feb 8, 2017D&A · Q4 FY2016: $76.0M · derived · 10-K 0000827054-17-000098 filed May 30, 2017D&A · Q1 FY2017: $113M · 10-Q 0000827054-16-000385 filed Aug 9, 2016D&A · Q2 FY2017: $113M · derived · 10-Q 0000827054-17-000203 filed Nov 7, 2017D&A · Q3 FY2017: $115M · derived · 10-Q 0000827054-18-000021 filed Feb 7, 2018D&A · Q4 FY2017: $128M · derived · 10-K 0001628280-18-006982 filed May 18, 2018D&A · Q1 FY2018: $152M · 10-Q 0000827054-18-000143 filed Aug 9, 2018D&A · Q2 FY2018: $153M · derived · 10-Q 0000827054-18-000249 filed Nov 7, 2018D&A · Q3 FY2018: $155M · derived · 10-Q 0000827054-19-000018 filed Feb 6, 2019D&A · Q4 FY2018: $157M · derived · 10-K 0000827054-19-000143 filed May 30, 2019D&A · Q1 FY2019: $173M · 10-Q 0000827054-18-000143 filed Aug 9, 2018D&A · Q2 FY2019: $221M · derived · 10-Q 0000827054-19-000288 filed Nov 6, 2019D&A · Q3 FY2019: $244M · derived · 10-Q 0000827054-20-000029 filed Feb 4, 2020D&A · Q4 FY2019: $239M · derived · 10-K 0000827054-20-000119 filed May 22, 2020D&A · Q1 FY2020: $307M · 10-Q 0000827054-19-000197 filed Aug 7, 2019D&A · Q2 FY2020: $298M · derived · 10-Q 0000827054-20-000278 filed Nov 5, 2020D&A · Q3 FY2020: $300M · derived · 10-Q 0000827054-21-000025 filed Feb 4, 2021D&A · Q4 FY2020: $311M · derived · 10-K 0000827054-21-000106 filed May 18, 2021D&A · Q1 FY2021: $293M · 10-Q 0000827054-20-000186 filed Aug 4, 2020D&A · Q2 FY2021: $286M · derived · 10-Q 0000827054-21-000280 filed Nov 4, 2021D&A · Q3 FY2021: $287M · derived · 10-Q 0000827054-22-000025 filed Feb 3, 2022D&A · Q4 FY2021: $288M · derived · 10-K 0000827054-22-000094 filed May 20, 2022D&A · Q1 FY2022: $272M · 10-Q 0000827054-21-000187 filed Aug 3, 2021D&A · Q2 FY2022: $278M · derived · 10-Q 0000827054-22-000193 filed Nov 3, 2022D&A · Q3 FY2022: $301M · derived · 10-Q 0000827054-23-000020 filed Feb 2, 2023D&A · Q4 FY2022: $293M · derived · 10-K 0000827054-23-000080 filed May 25, 2023D&A · Q1 FY2023: $259M · 10-Q 0000827054-22-000148 filed Aug 2, 2022D&A · Q2 FY2023: $252M · derived · 10-Q 0000827054-23-000185 filed Nov 2, 2023D&A · Q3 FY2023: $244M · derived · 10-Q 0000827054-24-000024 filed Feb 1, 2024D&A · Q4 FY2023: $243M · derived · 10-K 0000827054-24-000098 filed May 23, 2024D&A · Q1 FY2024: $223M · 10-Q 0000827054-23-000132 filed Aug 3, 2023D&A · Q2 FY2024: $219M · derived · 10-Q 0000827054-24-000206 filed Nov 5, 2024D&A · Q3 FY2024: $219M · derived · 10-Q 0000827054-25-000019 filed Feb 6, 2025D&A · Q4 FY2024: $218M · derived · 10-K 0000827054-25-000077 filed May 23, 2025D&A · Q1 FY2025: $189M · 10-Q 0000827054-24-000139 filed Aug 1, 2024D&A · Q2 FY2025: $188M · derived · 10-Q 0000827054-25-000183 filed Nov 6, 2025D&A · Q3 FY2025: $187M · derived · 10-Q 0000827054-26-000009 filed Feb 5, 2026D&A · Q4 FY2025: $187M · derived · 10-K 0000827054-26-000016 filed May 21, 2026D&A · Q1 FY2026: $171M · 10-Q 0000827054-25-000133 filed Aug 7, 2025D&A · Q2 FY2026: $173M · derived · 10-Q 0000827054-25-000183 filed Nov 6, 2025D&A · Q3 FY2026: $172M · derived · 10-Q 0000827054-26-000009 filed Feb 5, 2026D&A · Q4 FY2026: $174M · derived · 10-K 0000827054-26-000016 filed May 21, 2026D&A · Q1 FY2027: $157M · 10-Q 0000827054-26-000038 filed Aug 6, 2026288a15760311aQ1 FY2016Q1 FY2027Q4 FY2021
$MD&A · Q4 FY2020: $311M · derived · 10-K 0000827054-21-000106 filed May 18, 2021D&A · Q1 FY2021: $293M · 10-Q 0000827054-20-000186 filed Aug 4, 2020D&A · Q2 FY2021: $286M · derived · 10-Q 0000827054-21-000280 filed Nov 4, 2021D&A · Q3 FY2021: $287M · derived · 10-Q 0000827054-22-000025 filed Feb 3, 2022D&A · Q4 FY2021: $288M · derived · 10-K 0000827054-22-000094 filed May 20, 2022D&A · Q1 FY2022: $272M · 10-Q 0000827054-21-000187 filed Aug 3, 2021D&A · Q2 FY2022: $278M · derived · 10-Q 0000827054-22-000193 filed Nov 3, 2022D&A · Q3 FY2022: $301M · derived · 10-Q 0000827054-23-000020 filed Feb 2, 2023288a301a311aQ4 FY2020Q3 FY2022Q4 FY2021
Q4 FY2021
288a$M
derived
All values (45)
PeriodValue ($M)Status
Q1 FY2027157reported
Q4 FY2026174derived
Q3 FY2026172derived
Q2 FY2026173derived
Q1 FY2026171reported
Q4 FY2025187derived
Q3 FY2025187derived
Q2 FY2025188derived
Q1 FY2025189reported
Q4 FY2024218derived
Q3 FY2024219derived
Q2 FY2024219derived
Q1 FY2024223reported
Q4 FY2023243derived
Q3 FY2023244derived
Q2 FY2023252derived
Q1 FY2023259reported
Q4 FY2022293derived
Q3 FY2022301derived
Q2 FY2022278derived
Q1 FY2022272reported
Q4 FY2021288derived
Q3 FY2021287derived
Q2 FY2021286derived
Q1 FY2021293reported
Q4 FY2020311derived
Q3 FY2020300derived
Q2 FY2020298derived
Q1 FY2020307reported
Q4 FY2019239derived
Q3 FY2019244derived
Q2 FY2019221derived
Q1 FY2019173reported
Q4 FY2018157derived
Q3 FY2018155derived
Q2 FY2018153derived
Q1 FY2018152reported
Q4 FY2017128derived
Q3 FY2017115derived
Q2 FY2017113derived
Q1 FY2017113reported
Q4 FY201676derived
Q3 FY201676derived
Q2 FY201671derived
Q1 FY201660reported

CSV with all sources · Technical ID: dna

More metrics for Microchip

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Gross profit by segment

Sources & calculation
Value
$288M (derived)
Period
Q4 FY2021, ended Mar 31, 2021 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 1,153M − 866M = $288M (FY value from 10-K 0000827054-22-000094; 9-month value from the Q3-10-Q)
Source
10-K, filed May 20, 2022 · 0000827054-22-000094
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$288MMay 20, 202210-K 0000827054-22-000094derived · confidence 1. · current